Nasdaq-100 & Morningstar DBRS

Nasdaq-100: Nasdaq-100 is the chosen listing venue for SpaceX's IPO, with trading expected to begin on June 12. Nasdaq-100 has also changed its rules to allow SpaceX to quickly join the Nasdaq-100 100 index, which will drive institutional investment.

Morningstar DBRS: Morningstar DBRS>>> provided a contrarian valuation of SpaceX>>> at $780 billion, less than half of its target IPO valuation, citing concerns about its AI business and SpaceX — Starlink.

Nasdaq-100: SpaceX debuted on the Nasdaq-100 exchange, which revised its rules to allow for faster inclusion of major IPOs like SpaceX into its indexes, facilitating greater investor access.

Morningstar DBRS: Morningstar DBRS analysts expressed skepticism about SpaceX's valuation, calling it 'significantly overvalued' due to unproven technologies and capital needs.

Nasdaq-100: SpaceX>>> is set to join the Nasdaq-100>>> index after a rule change by the Nasdaq-100>>>, indicating its rapid integration into major market indices.

Morningstar DBRS: Morningstar DBRS's chief equity analyst, Michael Field, provided an expert opinion on AI companies burning cash and using public equity as a source of capital.

Nasdaq-100: SpaceX's inclusion in the Nasdaq-100 has not prevented its decline, and the index is affected by AI selloff.

Morningstar DBRS: Morningstar estimates SpaceX's fair value at $63 per share, significantly below current trading levels, indicating overvaluation.

Morningstar DBRS: Morningstar DBRS analysts have expressed skepticism about SpaceX's valuation, deeming it 'significantly overvalued' due to unproven technologies and high capital needs. They provided a lower valuation estimate for the company.

Morningstar DBRS: Morningstar DBRS's chief U.S. market strategist Dave Sekera expressed skepticism about Allbirds' AI pivot, questioning the company's expertise in data centers.